PL3027015T3 - Zwierzęta humanizowane IL-4 i IL-4R alfa - Google Patents

Zwierzęta humanizowane IL-4 i IL-4R alfa

Info

Publication number
PL3027015T3
PL3027015T3 PL15727106T PL15727106T PL3027015T3 PL 3027015 T3 PL3027015 T3 PL 3027015T3 PL 15727106 T PL15727106 T PL 15727106T PL 15727106 T PL15727106 T PL 15727106T PL 3027015 T3 PL3027015 T3 PL 3027015T3
Authority
PL
Poland
Prior art keywords
humanized
animals
alpha
alpha animals
Prior art date
Application number
PL15727106T
Other languages
English (en)
Inventor
Li-Hsien Wang
Yingzi Xue
Andrew J. Murphy
Sean Stevens
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Publication of PL3027015T3 publication Critical patent/PL3027015T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0368—Animal model for inflammation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Environmental Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL15727106T 2014-05-07 2015-05-07 Zwierzęta humanizowane IL-4 i IL-4R alfa PL3027015T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461989757P 2014-05-07 2014-05-07
EP15727106.5A EP3027015B1 (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals
PCT/US2015/029638 WO2015171861A1 (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals

Publications (1)

Publication Number Publication Date
PL3027015T3 true PL3027015T3 (pl) 2018-04-30

Family

ID=53284509

Family Applications (2)

Application Number Title Priority Date Filing Date
PL17193855T PL3281521T3 (pl) 2014-05-07 2015-05-07 Humanizowane zwierzęta il-4 i il-4r alfa
PL15727106T PL3027015T3 (pl) 2014-05-07 2015-05-07 Zwierzęta humanizowane IL-4 i IL-4R alfa

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL17193855T PL3281521T3 (pl) 2014-05-07 2015-05-07 Humanizowane zwierzęta il-4 i il-4r alfa

Country Status (25)

Country Link
US (7) US9565841B2 (pl)
EP (3) EP3027015B1 (pl)
JP (4) JP6640740B2 (pl)
KR (2) KR102517112B1 (pl)
CN (2) CN106470545B (pl)
AU (3) AU2015255977B2 (pl)
BR (1) BR112016025745A2 (pl)
CA (2) CA3207834A1 (pl)
CY (2) CY1119773T1 (pl)
DK (2) DK3027015T3 (pl)
ES (2) ES2656529T3 (pl)
HR (2) HRP20211455T1 (pl)
HU (2) HUE055860T2 (pl)
IL (3) IL248358B2 (pl)
LT (2) LT3027015T (pl)
MX (1) MX370672B (pl)
NO (1) NO2785538T3 (pl)
PH (1) PH12016502058A1 (pl)
PL (2) PL3281521T3 (pl)
PT (2) PT3027015T (pl)
RS (2) RS57073B1 (pl)
RU (1) RU2703139C2 (pl)
SG (2) SG11201608570YA (pl)
SI (2) SI3281521T1 (pl)
WO (1) WO2015171861A1 (pl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2785538T3 (pl) * 2014-05-07 2018-08-04
WO2015196051A1 (en) 2014-06-19 2015-12-23 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized programmed cell death 1 gene
WO2016042072A1 (en) * 2014-09-17 2016-03-24 Oerlikon Surface Solutions Ag, Trübbach Method for producing a double-layer coated cutting tool with improved wear resistance
HUE059417T2 (hu) 2014-11-24 2022-11-28 Regeneron Pharma Humanizált CD3-komplexet expresszáló nem humán állatok
EP4296278A3 (en) 2014-12-05 2024-03-27 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cluster of differentiation 47 gene
KR102457921B1 (ko) 2014-12-09 2022-10-25 리제너론 파마슈티칼스 인코포레이티드 인간화 분화 클러스터 274 유전자를 갖는 비인간 동물
KR102454546B1 (ko) 2015-11-20 2022-10-14 리제너론 파마슈티칼스 인코포레이티드 인간화 림프구 활성화 유전자 3을 갖는 비인간 동물
CN108779159B (zh) 2016-02-04 2022-12-30 瑞泽恩制药公司 具有经改造的angptl8基因的非人动物
ES2886958T3 (es) 2016-02-29 2021-12-21 Regeneron Pharma Roedores que tienen un gen TMPRSS humanizado
TWI784988B (zh) * 2016-12-01 2022-12-01 美商再生元醫藥公司 治療發炎症狀的方法
CA3059350A1 (en) 2017-04-13 2018-10-18 Regeneron Pharmaceuticals, Inc. Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding il33 and il1rl1
US11248054B2 (en) 2017-06-12 2022-02-15 Bluefin Biomedicine, Inc. Anti-IL1RAP antibodies and antibody drug conjugates
US20190098879A1 (en) 2017-09-29 2019-04-04 Regeneron Pharmaceuticals, Inc. Non-Human Animals Comprising A Humanized TTR Locus And Methods Of Use
CN116064611A (zh) 2017-11-30 2023-05-05 瑞泽恩制药公司 包含人源化trkb基因座的非人动物
SG11202008620VA (en) 2018-03-26 2020-10-29 Regeneron Pharma Humanized rodents for testing therapeutic agents
IL277890B2 (en) 2018-04-11 2024-03-01 Regeneron Pharma Methods for quantification of IL-33
JP7048051B2 (ja) 2018-07-11 2022-04-05 正徳 染井 痒みを軽減するアトピー性皮膚炎治療剤
AU2019308205A1 (en) * 2018-07-16 2020-11-19 Regeneron Pharmaceuticals, Inc. Non-human animal models of DITRA disease and uses thereof
CN111057721B (zh) * 2018-10-12 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化IL-4和/或IL-4Rα改造动物模型的制备方法及应用
CN114107385A (zh) * 2019-01-17 2022-03-01 百奥赛图(北京)医药科技股份有限公司 人源化转基因动物
KR102661779B1 (ko) 2019-04-04 2024-04-30 리제너론 파마슈티칼스 인코포레이티드 인간화 응고 인자 12 좌위를 포함하는 비-인간 동물
CA3137761A1 (en) 2019-06-04 2020-12-10 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use
IL288606B1 (en) 2019-06-07 2024-08-01 Regeneron Pharma Non-human animals containing a human albumin locus
CN112300265B (zh) * 2019-07-29 2022-09-27 百奥赛图(北京)医药科技股份有限公司 Il33基因人源化的非人动物的构建方法和应用
CN112430621B (zh) * 2019-08-09 2022-09-27 百奥赛图(北京)医药科技股份有限公司 Il2ra基因人源化的非人动物的构建方法及应用
EP4057807A4 (en) * 2019-11-11 2023-12-27 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GENES
US20220354097A1 (en) * 2019-12-25 2022-11-10 Gempharmatech Co., Ltd. Il-15 humanized mouse model and use thereof
CN115175559A (zh) * 2020-01-28 2022-10-11 瑞泽恩制药公司 包含人源化pnpla3基因座的非人动物及其使用方法
CN111149767B (zh) * 2020-02-24 2021-07-20 中南大学湘雅二医院 一种人源化皮肤型红斑狼疮小鼠模型的构建方法和应用
CN113527485A (zh) * 2020-04-17 2021-10-22 上海麦济生物技术有限公司 抗人白细胞介素-4受体α抗体及其制备方法和应用
CN111808882B (zh) * 2020-09-01 2020-12-29 北京百奥赛图基因生物技术有限公司 Il7r基因人源化改造的动物模型的构建方法及其应用
CN111793646B (zh) * 2020-09-08 2021-01-15 北京百奥赛图基因生物技术有限公司 Il1r1基因人源化改造的非人动物的构建方法及其应用
CN111926039B (zh) * 2020-09-23 2021-03-16 百奥赛图(北京)医药科技股份有限公司 Il-13基因人源化的非人动物的构建方法和应用
CA3171455A1 (en) * 2020-12-21 2022-06-30 Yajun Tang Non-human animals having a humanized tslp gene, a humanized tslp receptor gene, and/or a humanized il7ra gene
CN114835798B (zh) * 2021-05-28 2024-02-23 百奥赛图(北京)医药科技股份有限公司 Cd36基因人源化非人动物的构建方法及应用
WO2024067796A1 (zh) * 2022-09-28 2024-04-04 百奥赛图(北京)医药科技股份有限公司 一种il5和/或il5ra基因人源化修饰的非人动物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643427B2 (en) * 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
PL1802193T3 (pl) 2004-10-19 2014-09-30 Regeneron Pharma Sposób wytwarzania myszy homozygotycznej pod względem modyfikacji genetycznej
JP2007252370A (ja) * 2006-02-22 2007-10-04 Institute Of Physical & Chemical Research Ｉｌ−４初期発現系トランスジェニック非ヒト動物およびその利用
US20110016543A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genomic editing of genes involved in inflammation
WO2011002727A1 (en) * 2009-06-29 2011-01-06 Qingfeng Chen Methods of producing humanized non-human mammals
WO2011011767A1 (en) * 2009-07-24 2011-01-27 Sigma-Aldrich Co. Method for genome editing
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
PT3056082T (pt) 2009-10-06 2018-12-12 Univ Yale Ratinhos modificados geneticamente e enxerto
AU2012217836B2 (en) * 2011-02-15 2015-01-29 Institute For Research In Biomedicine (Irb) Humanized M-CSF mice
PT3272214T (pt) 2011-10-28 2020-03-04 Regeneron Pharma Ratinhos geneticamente modificados que expressam moléculas quiméricas de complexo principal de histocompatibilidade (mhc) ii
DK2818478T3 (en) * 2011-10-28 2017-05-22 Regeneron Pharma HUMANIZED IL-6 AND IL-6 RECEPTOR
SI3262932T1 (sl) 2011-10-28 2019-09-30 Regeneron Pharmaceuticals, Inc. Genetsko modificirani poglavitni histokompatibilnostni kompleks miši
US8962913B2 (en) * 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
SG11201500889TA (en) 2012-08-21 2015-03-30 Sanofi Sa Methods for treating or preventing asthma by administering an il-4r antagonist
CN113897398A (zh) 2012-09-07 2022-01-07 再生元制药公司 经遗传修饰的非人动物及其使用方法
PT3939423T (pt) 2012-11-05 2024-05-29 Regeneron Pharma Animais não humanos geneticamente modificados e métodos de utilização dos mesmos
ES2736052T3 (es) 2013-02-20 2019-12-23 Regeneron Pharma Ratones que expresan co-receptores humanizados de células T
EP3699190B9 (en) 2013-02-22 2023-10-04 Regeneron Pharmaceuticals, Inc. Murine cell expressing humanized major histocompatibility complex
JO3532B1 (ar) 2013-03-13 2020-07-05 Regeneron Pharma الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
EP2922394B1 (en) 2013-09-23 2017-02-22 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized signal-regulatory protein gene
CA2926090C (en) 2013-10-15 2022-07-05 Regeneron Pharmaceuticals, Inc. Humanized il-15 animals
KR102173260B1 (ko) 2013-11-19 2020-11-03 리제너론 파마슈티칼스 인코포레이티드 인간화된 b-세포 활성화 인자 유전자를 가지고 있는 비-인간 동물
US20150143559A1 (en) 2013-11-19 2015-05-21 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized a proliferation-inducing ligand gene
SG10201908800YA (en) 2014-04-08 2019-11-28 Regeneron Pharma Non-human animals having humanized fc-gamma receptors
WO2015171523A1 (en) 2014-05-05 2015-11-12 Regeneron Pharmaceuticals, Inc. Humanized c5 and c3 animals
NO2785538T3 (pl) 2014-05-07 2018-08-04

Also Published As

Publication number Publication date
KR20160150637A (ko) 2016-12-30
DK3027015T3 (en) 2018-01-22
AU2021218060B2 (en) 2024-04-11
US9565841B2 (en) 2017-02-14
PH12016502058A1 (en) 2017-01-09
US10477842B2 (en) 2019-11-19
US11109578B2 (en) 2021-09-07
LT3281521T (lt) 2021-09-27
KR102473565B1 (ko) 2022-12-02
IL297105B2 (en) 2024-01-01
US20180000056A1 (en) 2018-01-04
CN106470545A (zh) 2017-03-01
RU2703139C2 (ru) 2019-10-15
LT3027015T (lt) 2018-01-25
HUE038028T2 (hu) 2018-09-28
JP2021087434A (ja) 2021-06-10
KR102517112B1 (ko) 2023-04-03
US9743647B2 (en) 2017-08-29
RU2019131253A (ru) 2019-12-06
JP6640740B2 (ja) 2020-02-05
JP7145250B2 (ja) 2022-09-30
IL297105A (en) 2022-12-01
RU2016143376A (ru) 2018-06-09
US20200022344A1 (en) 2020-01-23
EP3281521A1 (en) 2018-02-14
AU2024204694A1 (en) 2024-09-05
CY1124605T1 (el) 2022-07-22
JP2017514501A (ja) 2017-06-08
EP3027015B1 (en) 2017-11-08
CY1119773T1 (el) 2018-06-27
PT3027015T (pt) 2018-02-09
US20210368753A1 (en) 2021-12-02
NO2785538T3 (pl) 2018-08-04
US20150320021A1 (en) 2015-11-12
ES2656529T3 (es) 2018-02-27
EP3906781A1 (en) 2021-11-10
EP3027015A1 (en) 2016-06-08
AU2015255977A1 (en) 2016-11-17
US20170311580A1 (en) 2017-11-02
CN106470545B (zh) 2019-08-20
IL304841A (en) 2023-09-01
IL248358B2 (en) 2023-03-01
CN110269047B (zh) 2021-11-02
ES2887852T3 (es) 2021-12-28
US10588298B2 (en) 2020-03-17
AU2015255977B2 (en) 2021-09-02
JP6838131B2 (ja) 2021-03-03
RS57073B1 (sr) 2018-06-29
SI3027015T1 (en) 2018-02-28
MX370672B (es) 2019-12-19
SG11201608570YA (en) 2016-11-29
RU2016143376A3 (pl) 2018-11-22
HRP20211455T1 (hr) 2022-01-07
CN110269047A (zh) 2019-09-24
IL248358B (en) 2022-11-01
JP2022171841A (ja) 2022-11-11
IL297105B1 (en) 2023-09-01
PT3281521T (pt) 2021-09-16
US20230027494A1 (en) 2023-01-26
US20150320022A1 (en) 2015-11-12
KR20220165814A (ko) 2022-12-15
MX2016014563A (es) 2017-02-23
SI3281521T1 (sl) 2021-11-30
CA2947307C (en) 2023-09-26
RS62345B1 (sr) 2021-10-29
BR112016025745A2 (pt) 2018-01-16
US11963521B2 (en) 2024-04-23
IL248358A0 (en) 2016-11-30
AU2021218060A1 (en) 2021-09-09
EP3281521B1 (en) 2021-06-30
JP2020058379A (ja) 2020-04-16
CA3207834A1 (en) 2015-11-12
SG10201912354PA (en) 2020-02-27
HRP20180242T1 (hr) 2018-03-09
PL3281521T3 (pl) 2022-01-03
HUE055860T2 (hu) 2021-12-28
DK3281521T3 (da) 2021-09-20
CA2947307A1 (en) 2015-11-12
WO2015171861A1 (en) 2015-11-12

Similar Documents

Publication Publication Date Title
IL297105B1 (en) Animals with il–4 and il–4r alpha of human origin
IL276946A (en) Antiproliferative compounds and methods of use
IL248481B (en) Animals containing c5 and c3 of human origin
IL252216B (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
IL284291A (en) Anti-acth antibodies from humans and their use
GB201401617D0 (en) Novel combination and use
IL247315A0 (en) Anti-acth antibodies and their uses
HK1243950A1 (zh) 新型組合物和用途
HK1243077A1 (zh) 呱啶基吡唑並嘧啶酮及其用途
GB201420805D0 (en) Ligatures and use thereof
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie